Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-10-26
2009-11-24
Gabel, Gailene R (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C436S501000, C436S518000
Reexamination Certificate
active
07622268
ABSTRACT:
The present invention provides a method for detecting autoantibodies in a subject which reacts with a GP73 antigen. Increased levels of GP73-specific autoantibodies in a sample from the subject which bind to GP73 antigen are indicative of liver disease in the subject.
REFERENCES:
patent: 4981785 (1991-01-01), Nayak
patent: 5358691 (1994-10-01), Clark et al.
patent: 5885530 (1999-03-01), Babson et al.
patent: 6159750 (2000-12-01), Edmonds
patent: 6548302 (2003-04-01), Mao et al.
patent: 6645725 (2003-11-01), Yeaman
patent: 2005/0037022 (2005-02-01), Rosen et al.
patent: 2005/0112711 (2005-05-01), Romano et al.
Bachert et al., “Endosomal Trafficking and Proprotein Convertase Cleavage ofcisGolgi Protein GP73 Produces Marker for Hepatocellular Carcinoma”,Traffic8(10):1415-1423 (Jul. 2007).
Block et al., “Use of Targeted Glycoproteomics to Identify Serum Glycoproteins That Correlate with Liver Cancer in Woodchucks and Humans”,PNAS102(3):779-784 (Jan. 18, 2005).
Block et al., “Surrogate Markers of Efficacy For Medical Treatment of Viral Hepatitis”,Biotechnology Healthcarepp. 42-48 (Oct. 2004).
Chignard et al., “Proteomics for Hepatocellular Carcinoma Marker Discovery”,Gastroenterology127(5):S120-S125 (Nov. 2004).
Gish, “Hepatocellular Carcinoma: Overcoming Challenges in Disease Management”,Clinical Gastroenterology and Hepatology4(3):252-261 (Mar. 2006).
Kladney et al, “Expression of GP73, A Resident Golgi Membrane Protein, in Viral and Nonviral Liver Disease”,Hepatology35(6):1431-1440 (Jun. 2002).
Iftikhar et al., “Disease- and Cell-Specific Expression of GP73 in Human Liver Disease”,American Journal of Gastroenterology99(6):1087-1095 (Jun. 2004).
Maitra et al., “GP73 and Liver Disease: A (Golgi) Complex Enigma”,American Journal of Gastroenterology99(6):1096-1098 (Jun. 2004).
Marrero et al., “Newer Markers for Hepatocellular Carcinoma”,Gastroenterology127(5):S113-S119 (Nov. 2004).
Paradis et al., “Identification of a New Marker of Hepatocellular Carcinoma by Serum Protein Profiling of Patients with Chronic Liver Disease”,Hepatology41(1):40-47 (Jan. 2005).
Puri et al., “Cycling of Early Golgi Proteins Via the Cell Surface and Endosomes Upon Lumenal pH Disruption”,Traffic3(9):641-653 (2002).
Schwegler et al., “SELDI-TOF MS Profiling of Serum for Detection of the Progression of Chronic Hepatitis C to Hepatocellular Carcinoma”, Hepatology 41(3):634-642 (Mar. 2005).
Xiao et al., “Cartilage Oligomeric Matrix Protein Expression in Hepatocellular Carcinoma and the Cirrhotic Liver”,Journal of Gastroenterology and Hepatology19:296-302 (2004).
Lutz et al., Humoral Immune Reactivity to Feline Leukemia Virus and Associated Antigens in Cats Naturally Infected with Feline Leukemia Virus, Cancer Research 40, 3642-3651. (Oct. 1980).
Marrero et al., GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma, Journal of Hepatolgoy 43, 1007-1012 (2005).
Wright et al., A concise review of serum markers for hepatocellular cancer. Cancer Detection and Prevention 31, 35-44. (2007). See pp. 37-38.
Kladney et al. “Upregulation of Golgi protein GP73 by adenovirus infection requires the EIA CtBP interaction domain”Virology301:236-46, 2002.
Kladney et al. GP73 a novel Golgi localized protein upregulated by viral infection:Gene249:53-65, 2000.
Norman Gary L.
Shums Zakera
Axford Laurie A.
Counts Gary W
Gabel Gailene R
INOVA Diagnostics, Inc.
The Nath Law Group
LandOfFree
Methods and assays for detecting GP73-specific autoantibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and assays for detecting GP73-specific autoantibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and assays for detecting GP73-specific autoantibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4103652